Zimmer Biomet Holdings (NYSE: ZBH) reported Q4 EPS of $2.42, $0.02 better than the analyst estimate of $2.40. Revenue for the quarter came in at $2.24 billion versus the consensus estimate of $2.22 billion.

GUIDANCE:

Zimmer Biomet Holdings sees FY2026 EPS of $8.30-$8.45, versus the consensus of $8.47.

For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.